- Country: Ukraine
- Summary: Cobas E411 Reagents (Dk 021: 2015 "33690000-3 Medicines Different")
- UAT Ref No: 127901467
- Deadline: 20 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 350918.64
- Notice Type: Tender
- Document Ref. No.: UA-2025-10-09-010438-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Type of purchase: goods
D III, ELECSYS immunoanalysis for quantitative determination of total 25-hydroxyvitamin D III, PRECICONTROL control for the test for the test for the test quantitative Determination of total 25-hydroxyvitamin D III, ELECSYS immunoanalysis for quantitative determination of insulin, set for calibration of the test for quantitative determination of insulin, set of ElecSYS reagents for quantitative determination quantitative determination of free prostatospecific antigen (Free PSA) - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCobas E411 Reagents (Dk 021: 2015 "33690000-3 Medicines Different") - Ukraine Tender
The MUNICIPAL NON -COMMERCIAL ENTERPRISE "CENTRAL CITY CLINICAL HOSPITAL" SUMY CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Cobas E411 Reagents (Dk 021: 2015 "33690000-3 Medicines Different"). This tender is published on UkraineTenders under UAT Ref No: 127901467 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-20.
The estimated tender value is UAH 350918.64, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
